🇺🇸 FDA
Patent

US 12319651

Crystalline forms and methods of producing crystalline forms of a compound

granted A61PA61P21/00

Quick answer

US patent 12319651 (Crystalline forms and methods of producing crystalline forms of a compound) held by Ligand Pharmaceuticals Incorporated expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P21/00